ATH 33.3% 0.4¢ alterity therapeutics limited

m123456, yes off label use will start for PD perhaps immediately...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,840 Posts.
    lightbulb Created with Sketch. 995
    m123456, yes off label use will start for PD perhaps immediately if BT434 will get to the pharmacy, perhaps also for AD. But to get PBT434 to millions of patients you need Ph 3 studies. Few thousands MSA and off label patients will make it possible, IMO.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.